Form D · Other Health Care

Proxima Bio, Inc.

New York, NY · CIK 0002104665

Offering snapshot reported Jun 10, 2026 · SEC filing

Reported sold
$91.5M
Offering amount: $91.5M
Investors reported
11
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Jan 12, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$45.7M$91.5MJan 21, 2026: $86,264,999.00Jan 21, 2026Jun 10, 2026: $91,454,999.00Jun 10, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$86,264,999 → $91,454,999

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 10, 2026Amendment$91,454,999$5,190,000vs Jan 21, 202611SEC filing
Jan 21, 2026Initial$86,264,999No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-570576

Source: Form D, filed Jun 10, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Zachary Carpenter Director, Executive
Alex Gasner Director
John Mc Farland Executive
Jason Pontin Director
Evan Schwartz Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
116 E 16 Th Street Floor 12
New York, NY, 10003